Why the study?
Does aliskiren improve survival and reduce renal fibrosis in a nonhypertensive mouse model of progressive renal fibrosis?
Population
6-week-old COL4A3 mice already showing renal damage
Comparison
Aliskiren administered via osmotic minipumps for… vs Placebo-treated control animals
Design
Preclinical
Follow-up
Until death from renal failure
Authors
Loading...
Aliskiren may confer BP-independent renal protection in mice; leaves open translation to human CKD.
Does aliskiren improve survival and reduce renal fibrosis in a nonhypertensive mouse model of progressive renal fibrosis?
Aliskiren prolonged survival and reduced renal fibrosis in a nonhypertensive mouse model, suggesting direct nephroprotective and antifibrotic effects independent of blood pressure lowering.
Girgert et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: